'A disease anywhere can be a disease everywhere tomorrow morning': Public health expert on Ebola and the threat of future outbreaks
Live Science spoke with Dr. Ali S. Khan, an epidemiologist and former assistant surgeon general of the U.S. Public Health Service, about the ongoing Ebola epidemic and the U.S.'s preparedness for fut…
Live Science spoke with Dr. Ali S. Khan, an epidemiologist and former assistant surgeon general of the U.S. Public Health Service, about the ongoing E
Read Full Story at Live Science →Why This Matters
The resurgence of Ebola in 2024 is more than a regional health crisis—it’s a stark reminder that infectious diseases are not bound by borders. Dr. Khan’s warning underscores a critical paradox: while global travel and trade accelerate the spread of pathogens, they also expose the fragility of public health systems that remain underprepared for rapid, cross-continental outbreaks. The stakes are existential, demanding a rethink of how nations allocate resources for pandemic preparedness.
Background Context
Ebola’s cyclical reemergence in Central Africa is deeply rooted in ecological and societal factors, from deforestation pushing wildlife into human settlements to entrenched distrust in healthcare systems. Decades of underfunding in local health infrastructure—exacerbated by colonial-era neglect and more recent geopolitical instability—have left regions like eastern DRC vulnerable to recurrent epidemics. Meanwhile, the U.S. response has oscillated between reactive deployments of medical aid and a broader erosion of public health funding post-2016.
What Happens Next
The coming months will test whether the global community can move beyond symbolic gestures, such as vaccine donations, to structural solutions like decentralized lab networks and community-based surveillance. Watch for signs that the WHO’s pandemic accord negotiations will yield enforceable commitments—or if national self-interest once again trumps collective action. A single missed transmission chain could spiral into a crisis far costlier than the 2014–2016 epidemic.
Bigger Picture
Ebola is a canary in the coal mine for a new era of zoonotic spillovers, where climate change and urban sprawl are colliding to create ideal conditions for novel pathogens. The disease’s persistence reveals a troubling pattern: progress in medical technology (e.g., experimental vaccines) is outpaced by systemic failures in governance, finance, and equity. Without addressing these root causes, future outbreaks—whether Ebola, Nipah, or something unknown—will continue to expose the hollow promises of global health security.
